Beken Bio
PrivateLast Round
Seed
Dec 10, 2026
Total Funding Raised
$2.28M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Beken Bio is a biotechnology company that develops minimally invasive liquid biopsy diagnostic tests for early cancer detection using AI-driven protein analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beken Bio Comparables
Compare Beken Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AOA Dx | 81% | |
| Dxcover | 77% | |
| InterVenn Biosciences | 77% |
Beken Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 10, 2026 | ||||
| Grant | Aug 11, 2026 | ||||
| Grant | Aug 15, 2024 |
Beken Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Community Development Venture Capital Alliance | Seed |
| Boot64 Ventures | Seed |
| New Orleans BioFund | Seed |
| Tulane Ventures | Seed |
| 1834 Ventures | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 10, 2026
$750K raised from 1834 Ventures and others.
- Aug 11, 2026
$1.25M grant from the National Science Foundation
Recent news
Latest coverage and updates
- receives_financingAug 11, 2026
Beken Bio, Inc. received financing of $1.25M in Small Business Innovation Research Phase II grant on Jan 1st '26.
Beken Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beken Bio's valuation, stock price, and market status.
Is Beken Bio a public or private company?
Beken Bio is a private company.
What is the current stock price of Beken Bio?
Beken Bio is a private company with no public stock price. Caplight tracks Beken Bio's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Beken Bio worth (valuation)?
Valuation information for Beken Bio is not publicly available.
Can I buy Beken Bio stock?
Beken Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beken Bio's last funding round?
Beken Bio's most recent funding round was Seed on December 10, 2026.
Who are the main investors in Beken Bio?
Key investors in Beken Bio include Community Development Venture Capital Alliance, Boot64 Ventures, New Orleans BioFund, Tulane Ventures, 1834 Ventures.
Will Beken Bio IPO soon?
No public IPO plans have been announced for Beken Bio.
How can I track Beken Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beken Bio's secondary market activity and sign up for updates.